Latest News & Developments
Egypt is transforming into Africa's pharmaceutical powerhouse, with 90% of drugs now produced locally. Through strategic BRICS partnerships, billion-dollar investments, and cutting-edge technology, Egypt is revolutionising healthcare access across Africa while building a $3 billion export industry by 2030. From vaccine manufacturing to Egyptian medical tourism, Cairo's ambitious vision is reshaping the continent's healthcare landscape.
South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over their insulin pen market practices, amid growing concerns about accessibility and pricing.
Cymbalta faces a recall as the FDA detects harmful levels of N-nitroso-duloxetine, a chemical linked to cancer.
Aspen Pharmacare Holdings has concluded agreements to acquire Sandoz (China) Pharmaceutical and its portfolio of products for up to €92. 6 million (R1. 89 billion), and to dispose of four anaesthetic products on sale in Europe.
It seems social media supersleuths have been busy, this after another ‘bogus’ medical practitioner has been outed.
Aspen said its subsidiary, Aspen Global Incorporated (AGI), had concluded the agreement on July 31, 2023. The fair value of the products had been determined by AGI as $280 million (R5. 08 billion).
Controversial Afrikaans singer,Steve Hofmeyr, has vowed never to shop at Dis-Chem again.
Dis-Chem says it noted a decline in sales at the time that its letter on the hiring of white staff was leaked to the public.
OPINION: Reducing HIV-related stigma is the new priority to improve the quality of life for all persons with HIV, writes Michael Buitron.
OPINION: ‘Normalisation’ of minting unbridled profits from illness, is one of the reasons why health and social welfare programmes have failed to deliver equitably, writes Shobha Shukla.
All Right ePharmacy’s ATM pharmacies have been permanently closed in Gauteng after three of the four sites were destroyed in riots, the company said on Tuesday.
Shares of drugmakers involved in the production of COVID-19 vaccines, including Pfizer and Moderna, fell on Thursday, a day after U. S. President Joe Biden's plan to back intellectual property waivers on vaccines.